A Two-Step Approach for the Design and Generation of Nanobodies
暂无分享,去创建一个
Hanna J Wagner | Sarah Wehrle | Etienne Weiss | Marco Cavallari | Wilfried Weber | H. J. Wagner | E. Weiss | W. Weber | S. Wehrle | M. Cavallari | Sarah Wehrle
[1] S. Tzipori,et al. Efficient Serum Clearance of Botulinum Neurotoxin Achieved Using a Pool of Small Antitoxin Binding Agents , 2009, Infection and Immunity.
[2] Stefan Ståhl,et al. Affibody Molecules in Biotechnological and Medical Applications. , 2017, Trends in biotechnology.
[3] A. Skerra,et al. Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Rajabibazl,et al. In Vivo Neutralization of Botulinum Neurotoxins Serotype E with Heavy-chain Camelid Antibodies (VHH) , 2013, Molecular Biotechnology.
[5] Nick Devoogdt,et al. (18)F-nanobody for PET imaging of HER2 overexpressing tumors. , 2016, Nuclear medicine and biology.
[6] S. Tzipori,et al. A Single VHH-Based Toxin-Neutralizing Agent and an Effector Antibody Protect Mice against Challenge with Shiga Toxins 1 and 2 , 2013, Infection and Immunity.
[7] A. Plückthun,et al. Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool. , 2001, Journal of molecular biology.
[8] E. Kabat,et al. Sequences of proteins of immunological interest , 1991 .
[9] Andreas Plückthun,et al. Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering. , 2004, Methods.
[10] S. Fanning,et al. An anti‐hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop , 2011, Protein science : a publication of the Protein Society.
[11] Heinrich Leonhardt,et al. Targeting and tracing antigens in live cells with fluorescent nanobodies , 2006, Nature Methods.
[12] M. Xian,et al. Recent advances in the selection and identification of antigen‐specific nanobodies , 2018, Molecular immunology.
[13] Shenghua Li,et al. Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library. , 2003, Journal of immunological methods.
[14] L. Presta,et al. Humanization of an anti-p185HER2 antibody for human cancer therapy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] G. Crooks,et al. WebLogo: a sequence logo generator. , 2004, Genome research.
[16] Frederic A. Fellouse,et al. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions. , 2004, Journal of molecular biology.
[17] Serge Muyldermans,et al. Nanobodies as Probes for Protein Dynamics in Vitro and in Cells* , 2015, The Journal of Biological Chemistry.
[18] N. Bec,et al. A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm , 2007, BMC biotechnology.
[19] Tristan J. Vaughan,et al. Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library , 1996, Nature Biotechnology.
[20] J. R. Horn,et al. Production and characterization of a genetically engineered anti-caffeine camelid antibody and its use in immunoaffinity chromatography. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[21] W. Marasco,et al. The growth and potential of human antiviral monoclonal antibody therapeutics , 2007, Nature Biotechnology.
[22] B. Jilma,et al. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. , 2016, The New England journal of medicine.
[23] Bruce D Hammock,et al. Isolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassay. , 2012, Analytical chemistry.
[24] J. Hubbell,et al. Covalently conjugated VEGF--fibrin matrices for endothelialization. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[25] A. Bhunia,et al. Deoxynivalenol-mimic nanobody isolated from a naïve phage display nanobody library and its application in immunoassay. , 2015, Analytica chimica acta.
[26] A. Plückthun,et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. , 2000, Journal of molecular biology.
[27] S. Muyldermans,et al. VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'. , 2008, Molecular immunology.
[28] A. Brunger,et al. A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate. , 2008, Structure.
[29] Hennie R. Hoogenboom,et al. A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies* , 1999, The Journal of Biological Chemistry.
[30] Jakub Toczek,et al. Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions , 2012, Circulation research.
[31] Yakun Wan,et al. Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications , 2014, Journal of Translational Medicine.
[32] Jacques Barbet,et al. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten. , 2007, Molecular immunology.
[33] S. Muyldermans,et al. General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold* , 2009, Journal of Biological Chemistry.
[34] J. Bluestone,et al. CD3-specific antibodies: a portal to the treatment of autoimmunity , 2007, Nature Reviews Immunology.
[35] C. Shoemaker,et al. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs). , 2007, Journal of immunological methods.
[36] Conor McMahon,et al. Yeast surface display platform for rapid discovery of conformationally selective nanobodies , 2018, Nature Structural & Molecular Biology.
[37] L. Wyns,et al. Camelid immunoglobulins and nanobody technology. , 2009, Veterinary immunology and immunopathology.
[38] P. Stewart,et al. Targeting G protein-coupled receptor signaling at the G protein level with a selective nanobody inhibitor , 2018, Nature Communications.
[39] D. G. Gibson,et al. Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.
[40] R. Zeldin,et al. Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura , 2017, Journal of thrombosis and haemostasis : JTH.
[41] Andrew D. Griffiths,et al. By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling , 1992, Bio/Technology.
[42] C. Eigenbrot,et al. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. , 2004, Journal of molecular biology.
[43] J. Rain,et al. NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies , 2016, eLife.
[44] Shohei Koide,et al. A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain , 2010, Nature Structural &Molecular Biology.
[45] Pauline M Rudd,et al. The impact of glycosylation on the biological function and structure of human immunoglobulins. , 2007, Annual review of immunology.
[46] Claudia Sheedy,et al. Selection, characterization, and CDR shuffling of naive llama single-domain antibodies selected against auxin and their cross-reactivity with auxinic herbicides from four chemical families. , 2006, Journal of agricultural and food chemistry.
[47] H. Ploegh,et al. Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma. , 2016, Angewandte Chemie.
[48] Frederic A. Fellouse,et al. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. , 2007, Journal of molecular biology.
[49] Yang Xu,et al. Isolation and characterisation of deoxynivalenol affinity binders from a phage display library based on single-domain camelid heavy chain antibodies (VHHs) , 2012 .
[50] G. Winter,et al. Antibody framework residues affecting the conformation of the hypervariable loops. , 1992, Journal of molecular biology.
[51] Andrew J. Martin,et al. Antibody-antigen interactions: contact analysis and binding site topography. , 1996, Journal of molecular biology.
[52] Mitchell Ho,et al. Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examples , 2017, mAbs.
[53] S. Muyldermans,et al. A general protocol for the generation of Nanobodies for structural biology , 2014, Nature Protocols.
[54] Serge Muyldermans,et al. Nanobodies: natural single-domain antibodies. , 2013, Annual review of biochemistry.
[55] B. Hammock,et al. VHH antibodies: emerging reagents for the analysis of environmental chemicals , 2016, Analytical and Bioanalytical Chemistry.
[56] L. Wyns,et al. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies. , 2005, Journal of molecular biology.
[57] Yakun Wan,et al. Generation of Small Single Domain Nanobody Binders for Sensitive Detection of Testosterone by Electrochemical Impedance Spectroscopy. , 2016, ACS applied materials & interfaces.
[58] Sachdev S Sidhu,et al. Molecular recognition by a binary code. , 2005, Journal of molecular biology.
[59] B. Hammock,et al. Competitive selection from single domain antibody libraries allows isolation of high-affinity antihapten antibodies that are not favored in the llama immune response. , 2011, Analytical chemistry.
[60] S. Muyldermans,et al. Nanobody®-based chromatin immunoprecipitation/micro-array analysis for genome-wide identification of transcription factor DNA binding sites , 2012, Nucleic acids research.
[61] G. Oyler,et al. Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases. , 2010, Toxicon : official journal of the International Society on Toxinology.
[62] Corella S. Casas-Delucchi,et al. Modulation of protein properties in living cells using nanobodies , 2010, Nature Structural &Molecular Biology.
[63] M. Uhlén,et al. Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain , 1997, Nature Biotechnology.
[64] Ira Mellman,et al. Antibody Therapeutics in Cancer , 2013, Science.
[65] H. Persson,et al. A focused antibody library for improved hapten recognition. , 2006, Journal of molecular biology.
[66] H. S. de Bruijn,et al. EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[67] J. Reichert,et al. Antibodies to watch in 2018 , 2018, mAbs.
[68] David G. Williams,et al. Humanising Antibodies by CDR Grafting , 2001 .
[69] S. Daunert,et al. Beyond Antibodies as Binding Partners: The Role of Antibody Mimetics in Bioanalysis. , 2017, Annual review of analytical chemistry.
[70] H. Ploegh,et al. Exploiting Nanobodies' Singular Traits. , 2018, Annual review of immunology.